These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15264742)
1. Presumed central anticholinergic syndrome from inadvertent intravenous hyoscine hydrobromide (scopolamine) injection. Wilden J; Rapeport D Anaesth Intensive Care; 2004 Jun; 32(3):419-22. PubMed ID: 15264742 [TBL] [Abstract][Full Text] [Related]
2. Three cases of substitution errors leading to hyoscine hydrobromide overdose. Van Sassenbroeck DK; Hemelsoet DM; Vanwalleghem P; Verstraete AG; Santens P; Monsieurs KG; Buylaert WA Clin Toxicol (Phila); 2005; 43(7):861-5. PubMed ID: 16440514 [TBL] [Abstract][Full Text] [Related]
3. Hyoscine butylbromide: a review of its use in the treatment of abdominal cramping and pain. Tytgat GN Drugs; 2007; 67(9):1343-57. PubMed ID: 17547475 [TBL] [Abstract][Full Text] [Related]
4. The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles. Laniado M; Grönewäller E; Kopp AF; Kaminsky SF; Hamm B; Jacobsen TF; Claussen CD Abdom Imaging; 1997; 22(4):381-8. PubMed ID: 9157855 [TBL] [Abstract][Full Text] [Related]
5. Physostigmine: going ... going ... gone? Two cases of central anticholinergic syndrome following anaesthesia and its treatment with physostigmine. Martin B; Howell PR Eur J Anaesthesiol; 1997 Jul; 14(4):467-70. PubMed ID: 9253580 [TBL] [Abstract][Full Text] [Related]
6. A case of hyoscine-related oesophagitis. Philcox S; Keegan A Med J Aust; 2007 Jun; 186(12):650-1. PubMed ID: 17576184 [TBL] [Abstract][Full Text] [Related]
7. Central cholinergic pathway involvement in the regulation of pupil diameter, blink rate and cognitive function. Naicker P; Anoopkumar-Dukie S; Grant GD; Neumann DL; Kavanagh JJ Neuroscience; 2016 Oct; 334():180-190. PubMed ID: 27531858 [TBL] [Abstract][Full Text] [Related]
8. Central anticholinergic syndrome from hyoscine hydrobromide in an unresponsive patient. Murphy D; Waldron D; Kennedy G; Molony J BMJ Support Palliat Care; 2024 Jan; 13(e3):e953-e956. PubMed ID: 36379687 [TBL] [Abstract][Full Text] [Related]
9. The role of routinely given hyoscine-N-butylbromide in colonoscopy: a double-blind, randomized, placebo-controlled, clinical trial. Ristikankare M; Karinen-Mantila H Scand J Gastroenterol; 2016 Mar; 51(3):368-73. PubMed ID: 26554619 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic effect of scopolamine butylbromide, a competitive antagonist of muscarinic acetylcholine receptor, on irinotecan-related cholinergic syndrome. Iihara H; Fujii H; Yoshimi C; Kobayashi R; Matsuhashi N; Takahashi T; Yoshida K; Suzuki A Cancer Chemother Pharmacol; 2019 Mar; 83(3):393-398. PubMed ID: 30564875 [TBL] [Abstract][Full Text] [Related]
11. Unexpected anterograde amnesia associated with Buscopan used as a predmedication for endocscopy. Lee H; Son HJ; Rhee PL; Kim JJ; Rhee JC World J Gastroenterol; 2007 Jul; 13(28):3895-6. PubMed ID: 17657850 [TBL] [Abstract][Full Text] [Related]
12. Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. Wildiers H; Dhaenekint C; Demeulenaere P; Clement PM; Desmet M; Van Nuffelen R; Gielen J; Van Droogenbroeck E; Geurs F; Lobelle JP; Menten J; J Pain Symptom Manage; 2009 Jul; 38(1):124-33. PubMed ID: 19361952 [TBL] [Abstract][Full Text] [Related]
13. The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function. Golding JF; Wesnes KA; Leaker BR Br J Clin Pharmacol; 2018 Jul; 84(7):1535-1543. PubMed ID: 29522648 [TBL] [Abstract][Full Text] [Related]
14. Hyperthermia associated with central anticholinergic syndrome caused by a transdermal hyoscine patch in a child with cerebral palsy. Frampton A; Spinks J Emerg Med J; 2005 Sep; 22(9):678-9. PubMed ID: 16113205 [No Abstract] [Full Text] [Related]
16. Effect of intravenous hyoscine-N-butyl bromide on active phase of labor progress: a randomized double blind placebo controlled trial. Kirim S; Asicioglu O; Yenigul N; Aydogan B; Bahat N; Bayrak M J Matern Fetal Neonatal Med; 2015 Jun; 28(9):1038-42. PubMed ID: 25023433 [TBL] [Abstract][Full Text] [Related]
17. Acute onset psychosis with complex neurobehavioural symptomatology following the intramuscular injection of hyoscine butylbromide: a case report with an overview of the literature. Bulut NS; Arpacıoğlu ZB Eur J Hosp Pharm; 2022 Sep; 29(5):294-297. PubMed ID: 33376193 [TBL] [Abstract][Full Text] [Related]
18. Galanthamine hydrobromide, a longer acting anticholinesterase drug, in the treatment of the central effects of scopolamine (Hyoscine). Cozanitis DA Anaesthesist; 1977 Dec; 26(12):649-50. PubMed ID: 603022 [TBL] [Abstract][Full Text] [Related]
19. The effect of hyoscine n- butylbromide on labor progress: A systematic review. Mohaghegh Z; Abedi P; Faal S; Jahanfar S; Surdock A; Sharifipour F; Zahedian M BMC Pregnancy Childbirth; 2020 May; 20(1):291. PubMed ID: 32404072 [TBL] [Abstract][Full Text] [Related]
20. Response to Hyoscine Butylbromide for the Management of Death Rattle: Sooner Rather Than Later. Campbell ML J Pain Symptom Manage; 2019 Jan; 57(1):e14-e15. PubMed ID: 30248383 [No Abstract] [Full Text] [Related] [Next] [New Search]